CN110495607A - A kind of procyanidine oligosaccharide endocrine metabolic diseases powder and preparation method - Google Patents
A kind of procyanidine oligosaccharide endocrine metabolic diseases powder and preparation method Download PDFInfo
- Publication number
- CN110495607A CN110495607A CN201910908057.4A CN201910908057A CN110495607A CN 110495607 A CN110495607 A CN 110495607A CN 201910908057 A CN201910908057 A CN 201910908057A CN 110495607 A CN110495607 A CN 110495607A
- Authority
- CN
- China
- Prior art keywords
- powder
- procyanidine
- oligosaccharide
- mct
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 113
- 230000002124 endocrine Effects 0.000 title claims abstract description 45
- 208000030159 metabolic disease Diseases 0.000 title claims abstract description 41
- 229920001542 oligosaccharide Polymers 0.000 title claims abstract description 41
- 150000002482 oligosaccharides Chemical class 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 229920001202 Inulin Polymers 0.000 claims abstract description 39
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 39
- 229940029339 inulin Drugs 0.000 claims abstract description 39
- 239000000419 plant extract Substances 0.000 claims abstract description 26
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 24
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 22
- 238000000605 extraction Methods 0.000 claims abstract description 15
- 244000269722 Thea sinensis Species 0.000 claims description 36
- 230000000694 effects Effects 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 20
- 239000000284 extract Substances 0.000 claims description 17
- 108090000790 Enzymes Proteins 0.000 claims description 13
- 102000004190 Enzymes Human genes 0.000 claims description 13
- 235000013399 edible fruits Nutrition 0.000 claims description 13
- 239000003866 digestant Substances 0.000 claims description 12
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims description 12
- 235000008696 isoflavones Nutrition 0.000 claims description 12
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 claims description 11
- 229920002774 Maltodextrin Polymers 0.000 claims description 10
- 239000005913 Maltodextrin Substances 0.000 claims description 10
- 241000219095 Vitis Species 0.000 claims description 10
- 229940035034 maltodextrin Drugs 0.000 claims description 10
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 8
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 7
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 7
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 7
- 230000013595 glycosylation Effects 0.000 claims description 7
- 238000006206 glycosylation reaction Methods 0.000 claims description 7
- 108010055615 Zein Proteins 0.000 claims description 6
- 229920002494 Zein Polymers 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 239000011812 mixed powder Substances 0.000 claims description 6
- 241000533293 Sesbania emerus Species 0.000 claims description 5
- 239000011259 mixed solution Substances 0.000 claims description 5
- 235000010204 pine bark Nutrition 0.000 claims description 5
- 235000009392 Vitis Nutrition 0.000 claims description 4
- 238000004090 dissolution Methods 0.000 claims description 4
- 239000000839 emulsion Substances 0.000 claims description 4
- 210000000582 semen Anatomy 0.000 claims description 4
- 238000007873 sieving Methods 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000007605 air drying Methods 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000006210 lotion Substances 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- 239000000243 solution Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 claims description 2
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 claims description 2
- 244000241838 Lycium barbarum Species 0.000 claims 1
- 235000015459 Lycium barbarum Nutrition 0.000 claims 1
- 235000015468 Lycium chinense Nutrition 0.000 claims 1
- 240000006365 Vitis vinifera Species 0.000 claims 1
- 229930003944 flavone Natural products 0.000 claims 1
- 150000002213 flavones Chemical class 0.000 claims 1
- 235000011949 flavones Nutrition 0.000 claims 1
- 238000010521 absorption reaction Methods 0.000 abstract description 14
- 208000017520 skin disease Diseases 0.000 abstract description 10
- 230000028327 secretion Effects 0.000 abstract description 8
- 230000003750 conditioning effect Effects 0.000 abstract description 6
- 201000010099 disease Diseases 0.000 abstract description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 6
- 230000036541 health Effects 0.000 abstract description 6
- 241001122767 Theaceae Species 0.000 abstract description 5
- 230000001815 facial effect Effects 0.000 abstract description 5
- 238000002156 mixing Methods 0.000 abstract description 5
- 230000002195 synergetic effect Effects 0.000 abstract description 5
- 210000004907 gland Anatomy 0.000 abstract description 4
- 235000013616 tea Nutrition 0.000 description 29
- 230000000052 comparative effect Effects 0.000 description 17
- 230000009102 absorption Effects 0.000 description 13
- 210000003491 skin Anatomy 0.000 description 10
- 229930014669 anthocyanidin Natural products 0.000 description 7
- 235000008758 anthocyanidins Nutrition 0.000 description 7
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 239000004365 Protease Substances 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 5
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 5
- -1 DPPH free radical Chemical class 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 208000003351 Melanosis Diseases 0.000 description 4
- 102000003425 Tyrosinase Human genes 0.000 description 4
- 108060008724 Tyrosinase Proteins 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 230000002000 scavenging effect Effects 0.000 description 4
- 208000002874 Acne Vulgaris Diseases 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 108090000526 Papain Proteins 0.000 description 3
- 244000046146 Pueraria lobata Species 0.000 description 3
- 235000010575 Pueraria lobata Nutrition 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 201000005630 leukorrhea Diseases 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 206010046901 vaginal discharge Diseases 0.000 description 3
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 2
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 description 2
- 108010004032 Bromelains Proteins 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010008570 Chloasma Diseases 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 235000011201 Ginkgo Nutrition 0.000 description 2
- 235000008100 Ginkgo biloba Nutrition 0.000 description 2
- 244000194101 Ginkgo biloba Species 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 235000003434 Sesamum indicum Nutrition 0.000 description 2
- 244000000231 Sesamum indicum Species 0.000 description 2
- 235000015724 Trifolium pratense Nutrition 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000019835 bromelain Nutrition 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 235000014103 egg white Nutrition 0.000 description 2
- 210000000969 egg white Anatomy 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 229940118199 levulan Drugs 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000005075 mammary gland Anatomy 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- 230000009245 menopause Effects 0.000 description 2
- 230000003821 menstrual periods Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 229940055729 papain Drugs 0.000 description 2
- 235000019834 papain Nutrition 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 235000013526 red clover Nutrition 0.000 description 2
- 210000001732 sebaceous gland Anatomy 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 206010040882 skin lesion Diseases 0.000 description 2
- 231100000444 skin lesion Toxicity 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 description 1
- CODAYFPFZXWNLD-UHFFFAOYSA-N 2-hydroxypropanoyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(=O)C(C)O CODAYFPFZXWNLD-UHFFFAOYSA-N 0.000 description 1
- 241000143437 Aciculosporium take Species 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108090000270 Ficain Proteins 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 240000000950 Hippophae rhamnoides Species 0.000 description 1
- 235000003145 Hippophae rhamnoides Nutrition 0.000 description 1
- 241001290534 Lachnocaulon Species 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 241000209445 Nelumbonaceae Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 201000009916 Postpartum depression Diseases 0.000 description 1
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 description 1
- MOJZMWJRUKIQGL-FWCKPOPSSA-N Procyanidin C2 Natural products O[C@@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@H]3[C@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@@H]1c1c(O)cc(O)c2c1O[C@@H]([C@H](O)C2)c1cc(O)c(O)cc1 MOJZMWJRUKIQGL-FWCKPOPSSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 208000002495 Uterine Neoplasms Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 210000004883 areola Anatomy 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- 229940125691 blood product Drugs 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 235000013341 fat substitute Nutrition 0.000 description 1
- 239000003778 fat substitute Substances 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 235000019836 ficin Nutrition 0.000 description 1
- POTUGHMKJGOKRI-UHFFFAOYSA-N ficin Chemical compound FI=CI=N POTUGHMKJGOKRI-UHFFFAOYSA-N 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 229940087603 grape seed extract Drugs 0.000 description 1
- 235000002532 grape seed extract Nutrition 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 208000006575 hypertriglyceridemia Diseases 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000015263 low fat diet Nutrition 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 150000004667 medium chain fatty acids Chemical class 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 229940100688 oral solution Drugs 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 230000000803 paradoxical effect Effects 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 210000003240 portal vein Anatomy 0.000 description 1
- HGVVOUNEGQIPMS-UHFFFAOYSA-N procyanidin Chemical compound O1C2=CC(O)=CC(O)=C2C(O)C(O)C1(C=1C=C(O)C(O)=CC=1)OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 HGVVOUNEGQIPMS-UHFFFAOYSA-N 0.000 description 1
- 229920002414 procyanidin Polymers 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 230000035946 sexual desire Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 235000021139 traditional diet Nutrition 0.000 description 1
- 206010046766 uterine cancer Diseases 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000001717 vitis vinifera seed extract Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/06—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Botany (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention provides a kind of procyanidine oligosaccharide endocrine metabolic diseases powder and preparation method, compare according to parts by weight, including following component: 10-20 parts of 70~90 parts of 3~6 parts of plant extracts, inulin, the MCT powder of procyanidine >=95%, 1-2 parts of ground coffee, tea polyphenols >=95% 0.5-1.5 parts of 0.5-1.5 parts of tea extraction, water soluble pearl powder.The present invention selects procyanidine to be combined with inulin, MCT powder, ground coffee, tea polyphenols and water soluble pearl powder, obtained procyanidine oligosaccharide endocrine metabolic diseases powder, not only with the good synergistic effect for adjusting and digesting and assimilating, increase absorption rate, and the inoxidizability that is conducive to procyanidine, tea polyphenols etc. in body, it improves and removes interior free yl ability, conditioning effect is more significant, it takes after mixing it with water conveniently, effective in the powder class health product of facial area skin disorder caused by treatment dyschromicum skin disease and skin gland secretion obstacle disease.
Description
Technical field
The present invention relates to technical field of health care food, in particular to a kind of procyanidine oligosaccharide endocrine metabolic diseases powder and system
Preparation Method.
Background technique
It is confirmed through modern medicine theory, the skin disorders such as chloasma, freckle, dark sore, acne belong to dyschromicum and skin more
Skin gland obstacle dermatoses, though suffering from facial area skin, the cause of disease is derived from that interior free yl is excessive, pituitary or hypothalamus
Endocrine disturbance, the reasons such as enteron aisle digestive system is bad, caused cell survival shorten, and dysovarism is just secreted, and make ovary
Generation estrogen function is low, and sex hormone excitement melanocyte and pregnant reward influence menoxenia, sebaceous glands caused to increase
Greatly, sebum secretion increases, and melanin increase, stasis of blood product, are in crineous, yellowish-brown, reddish brown color spot after ultraviolet light irradiates at skin lesion
The problems such as point or such as hatpin head size cone acne.
The product of the skin disorders such as chloasma, freckle, the acne that treatment facial area suffers from present is broadly divided into the painting of external application
Cloth product and health food for oral administration, but the coated product of external application tends not to the problem of eradicating skin disorder, or even is easy to produce
The case where raw recurrence, high recurrence rate is palliative;And for health food for oral administration, such as oral solution, capsule health care food
Product contain the plant extracts such as inoxidizability using it, and for adjusting the endocrine and digestion and absorption of body, but working as will be different
Function ingredients are combined compounding, into body after the inoxidizability of effective component that often contains reduce, efficacy effect is unknown
Aobvious, cannot be decomposed absorption completely, and absorption rate is low, and conditioning effect is not significant, and patient's treatment cost is caused to greatly increase
The problem of, therefore, it is necessary to develop, a kind of absorption rate is high, the significant endocrine metabolic diseases product of function and effect.
Summary of the invention
In consideration of it, the present invention proposes in a kind of promotion absorption rate and the significant procyanidine oligosaccharide of conditioning effect point
It secretes and adjusts powder and preparation method.
The technical scheme of the present invention is realized as follows:
The present invention provides a kind of procyanidine oligosaccharide endocrine metabolic diseases powder, compares according to parts by weight, including following component:
A kind of procyanidine oligosaccharide endocrine metabolic diseases powder proposed by the present invention not only selects procyanidine and tea polyphenols etc.
Function ingredients, while to protect the biochemical composition of intraor extracellular from free radical attack, further preferably inulin, MCT powder, coffee
Powder and water soluble pearl powder are combined, and are obtained procyanidine oligosaccharide endocrine metabolic diseases powder, can not only be reached effective tune
The synergistic effect digested and assimilated is saved, the decomposition of effective component is promoted to absorb, increases absorption rate, and be conducive to former cyanine
The inoxidizability in body such as element, tea polyphenols extends its effective component in people's intracorporal action time, effectively removes in vivo freely
Base, conditioning effect is more significant, takes after mixing it with water conveniently, can hinder effectively as treating dyschromicum skin disease and skin gland secretion
Hinder the powder class health product of facial area skin disorder caused by disease.
It further illustrates, compares according to parts by weight, further include the plant extracts of 0-1 parts of isoflavone content >=40%.Institute
The plant for stating isoflavone content >=40% is the plant rich in isoflavones such as pueraria lobata and soybean, sesame, red clover, mass ratio
Are as follows: pueraria lobata: soybean: red clover=1:(0~0.5): (0~0.5).
It further illustrates, compares according to parts by weight, further include 0-1 parts of digestant 200,000 unit of activity/gram edible proteins
Enzyme.The digestant edible protein enzyme includes papain, bromelain, ficin, wherein Papain
The mass ratio of enzyme and bromelain is 1:(0~0.5).
It further illustrates, compares according to parts by weight, including following component:
It further illustrates, the extraction raw material of procyanidine >=95% are as follows: grape pip, pine bark and black fruit fructus lycii,
The mass ratio of Semen Vitis viniferae extract, Pine Bark and black fruit fructus lycii extract is (1~2): (1~3): (0.5~1).Root
According to the mass ratio of the procyanidin extract of above-mentioned raw materials, be allowed to inulin, MCT powder, ground coffee combination acts synergistically under, mention
High definition removes the ability of interior free yl.
The extraction raw material of procyanidine >=95% can be with are as follows: Grape Skin, ginkgo leaf, tealeaves and Nelumbonaceae axis, leaf,
Root, fruit, skin and cocoa, ' Heijialun ' seed, sea-buckthorn, lichee, hawthorn, strawberry, the other plants such as beans.The tea of tea polyphenols >=95% mentions
Taking object is green-tea extract, and the tea of tea polyphenols >=95% is that the Theaceaes plants and sesame, purple perilla etc. such as green tea, black tea are rich in tea polyphenols
Other plant.
It further illustrates, the inulin is the glycosylation inulin of the zeins containing mass ratio 0.05~0.1%
Mixture.It is combined by using a certain amount of inulin with the plant extracts of procyanidine >=95%, using by corn alcohol
It is molten it is protein modified after glycosylation inulin mixtures, fat metabolism and the absorption of minerals can not only be effectively improved, tieed up simultaneously
It is active in body to hold procyanidine, tea polyphenols etc., extends its effective component in people's intracorporal action time, improves and remove in vivo
The ability of free radical.
It further illustrates, it is 0.3~1% maltodextrin and 0.1~2% monoglyceride that the MCT powder, which is containing mass ratio,
MCT powder mixture.By using above-mentioned MCT powder mixture, can not only be inhaled with group subassembly, effectively adjusting digestion such as inulin
The synergistic effect of receipts maintains to stablize the release and absorption rate of medium chain triglyceride (MCT) in human body, and enhances original simultaneously
Anthocyanidin extends action time the body the effect of.
It further illustrates, the preparation method of the MCT powder includes the following steps:
(1) MCT, maltodextrin, monoglyceride are weighed in proportion, is added to the water dissolution, and 5~10min is mixed, obtains
MCT mixed solution;
(2) MCT mixed solution is recycled 2~3 times under 80~100Mpa pressure using high pressure homogenizer, obtains MCT cream
Liquid;
(3) MCT emulsion spray is dry, sieving obtains finished product MCT powder.
It further illustrates, the ground coffee is that either shallow bakes 6~10min at 160~180 DEG C, and is ground to partial size and is
15~20 μm of coffee bean powder.Obtained coffee bean powder is baked and ground by using either shallow at a certain temperature, is adjusted to people
PH value in body enteron aisle is conducive to the diffusion of the activity and effective component that maintain procyanidine in body, promotes to digest and assimilate.
A kind of preparation method of procyanidine oligosaccharide endocrine metabolic diseases powder, includes the following steps:
(1) tea of the plant extracts of procyanidine >=95%, inulin, MCT powder, ground coffee, tea polyphenols >=95% is mentioned
Take the plant extracts of object, water soluble pearl powder, isoflavone content >=40%, digestant 200,000 unit of activity/gram table egg
White enzyme crosses 80~100 meshes through heated-air drying and obtains even-grained dry fine powder respectively after ultraviolet disinfection;
(2) weigh the drying fine powder that step (1) obtains in proportion: the plant extracts of procyanidine >=95%, inulin,
MCT powder, ground coffee, enter and mix 30-40min in three-dimensional mixer;Obtain preliminary mixed powder;
(3) the drying fine powder that step (1) obtains: tea extraction, the water-soluble pearl of tea polyphenols >=95% is weighed in proportion
Powder, the plant extracts of isoflavone content >=40%, in digestant 200,000 unit of activity/gram edible protein enzyme, with step (2)
Preliminary mixed powder mix 20~30min in three-dimensional mixer, packing, sterilizing obtain packed procyanidine oligosaccharide
Endocrine metabolic diseases medicinal granules of powder.
Compared with prior art, the beneficial effects of the present invention are: the present invention not only selects the function such as procyanidine and tea polyphenols
Can component, while to protect the biochemical composition of intraor extracellular from free radical attack, further preferably inulin, MCT powder, ground coffee
It is combined with water soluble pearl powder, obtains procyanidine oligosaccharide endocrine metabolic diseases powder, effective adjusting can not only be reached
The synergistic effect of digestion and absorption promotes the decomposition of effective component to absorb, increase absorption rate, and be conducive to procyanidine,
The inoxidizability in body such as tea polyphenols extends its effective component in people's intracorporal action time, effectively removes interior free yl,
Conditioning effect is more significant, takes after mixing it with water conveniently, can be effectively as treating dyschromicum skin disease and skin gland secretion obstacle
The powder class health product of facial area skin disorder caused by disease.
Specific embodiment
In order to be best understood from the technology of the present invention content, specific embodiment is provided below, the present invention is described further.
Experimental method used in the embodiment of the present invention is conventional method unless otherwise specified.
Material used in the embodiment of the present invention, reagent etc., are commercially available unless otherwise specified.
According to modernization of Chinese medicine theory, grape seed extract of the present invention, Pine Bark, black fruit fructus lycii extract, green tea
The effective ingredients such as extract have the function of removing interior free yl based on polyphenol.
Inulin (inulin) is as fructose through linear straight chain polysaccharide made of β (2 → 1) key connection, and end often has one
Glucose, the degree of polymerization are 2~60.Inulin is actually also the mixture of a variety of different polymerization degree levulan, wherein the degree of polymerization compared with
The levulan of low (DP=2~9) is commonly referred to as oligofructose.According to inulin sources difference.Oligofructose content one in inulin
As differ for 5%~35%.Inulin is not decomposed in oral cavity, stomach, small enteral, absorbs.In colon by beneficial bacterium (bifid bar
Bacterium, lactobacillus etc.) it utilizes, it is a kind of soluble dietary fiber and a kind of fat substitute, while still a kind of effective double
Discrimination bacillus proliferation factor.It is a kind of novel feed addictive as a kind of beneficial microbial substrates, alternative promotes to have
Beneficial bacteria growth, in animal body noresidue do not develop drug resistance, can improve the fat metabolism of animal, improve the suction of minerals
It receives.Inulin is a kind of worth exploitation and the product resource applied to feedstuff industry.
MCT powder.Blood triglyceride levels can preferably be maintained using the medium chain fatty acid in medium chain triglyceride, to
II diabetic of hypertriglyceridemia is advantageous, and medium chain triglyceride loses weight to type II diabetes (T2DM) patient,
The risk that the complication such as coronary heart disease occur is reduced to have very great help.Type II diabetes (T2DM) patient is usually than non-diabetic person
With higher weight, the risk that the complication such as coronary heart disease occur for T2DM can be reduced by losing weight.Subtract by adjusting diet
Fertilizer, safety are substantially better than drug effect, but the long-term tradition low-fat diet that carries out may cause the loss of liposoluble vitamin, institute
On the basis of controlling gross energy, to improve lipid intake quality and constitute extremely important.Medium chain triglyceride (MCT) is easy to inhale
It receives, directly liver is transported to by portal vein and does not depend on carnitine and can directly be aoxidized rapidly, do not easily cause fat
Storage, can replace parts of traditional diet grease long chain triglycerides (LCT).Use the sunflower for being rich in monounsaturated fatty acids
The compound grease such as oil, olive oil, palm oil can reduce the level of triglycerides and total cholesterol in patients blood plasma, reduce painstaking effort
Pipe disease is dangerous, improves immune function since monounsaturated fatty acids contains only single unsaturated double-bond and is not susceptible to peroxidating,
It is smaller to lipid.
Kudzu root extract can effectively increase cortex hormone of aadrenaline secretion activity, exclude dysovarism, improve ovary
Hypofunction morbid state, accelerates estrogen secretion, controls melanocyte and progesterone steadily breeds and withers away, so that sebaceous glands be made to contract
Small, sebum secretion is reduced, and is promoted melanin at patient face skin lesion to reduce, and have activation to the regeneration of Skin Cell, is made
The reproduction speed of Skin Cell can be improved as many as 22-35 times;Water soluble pearl powder contains several physiological active substances, Papain
Enzyme has the effect for adjusting system of assimilating;There are also flavonoid glycosides for Pine Bark effective ingredient, have invigorating qi for strengthening superficies, diuresis anti-
Poison arranges dense, expelling pus and promoting granulation function;The collaboration of each effective component in patient's body collective effect, can not only from remove interior free yl,
It adjusts endocrine and is acted in terms of adjusting digestive system three, and strengthen absorption rate and Scavenging ability, improve
Effect is more significant, takes after mixing it with water conveniently, has no toxic side effect.
A kind of procyanidine oligosaccharide endocrine metabolic diseases powder of embodiment 1-, compares, including following component according to parts by weight: former
The tea extraction of 10 parts of 70 parts of 3 parts of plant extracts, inulin, the MCT powder of anthocyanidin >=95%, 2 parts of ground coffee, tea polyphenols >=95%
1.5 parts of object, 0.5 part of water soluble pearl powder.
A kind of procyanidine oligosaccharide endocrine metabolic diseases powder of embodiment 2-, compares, including following component according to parts by weight: former
The tea extraction of 12 parts of 80 parts of 6 parts of plant extracts, inulin, the MCT powder of anthocyanidin >=95%, 1 part of ground coffee, tea polyphenols >=95%
1.2 parts of object, 1.5 parts of water soluble pearl powder.
Wherein, the extraction raw material of procyanidine >=95% are as follows: grape pip, pine bark and black fruit fructus lycii, grapestone
The mass ratio of extract, Pine Bark and black fruit fructus lycii extract is 1:1:0.5.
A kind of procyanidine oligosaccharide endocrine metabolic diseases powder of embodiment 3-, compares, including following component according to parts by weight: former
20 parts of 90 parts of 4 parts of plant extracts, inulin, the MCT powder of anthocyanidin >=95%, 1.5 parts of ground coffee, tea polyphenols >=95% tea mention
0.5 part of object, 0.8 part of water soluble pearl powder, 0.5 part of the plant extracts of isoflavone content >=40%, digestant 200,000 are taken to live
Unit of force/1 part of gram edible protein enzyme.
Wherein, the extraction raw material of procyanidine >=95% are as follows: grape pip, pine bark and black fruit fructus lycii, grapestone
The mass ratio of extract, Pine Bark and black fruit fructus lycii extract is 1:1:0.5;The inulin is to contain mass ratio
The glycosylation inulin mixtures of 0.05% zeins;The MCT powder be containing mass ratio be 0.3% maltodextrin and
The MCT powder mixture of 0.1% monoglyceride;The ground coffee is that either shallow bakes 10min at 160 DEG C, and being ground to partial size is 15
~20 μm of coffee bean powder.
The preparation method of the MCT powder, includes the following steps:
(1) MCT, maltodextrin, monoglyceride are weighed in proportion, is added to the water dissolution, 5min is mixed, and it is mixed to obtain MCT
Close solution;
(2) MCT mixed solution is recycled 2 times under 100Mpa pressure using high pressure homogenizer, obtains MCT lotion;
(3) MCT emulsion spray is dry, sieving obtains finished product MCT powder.
A kind of procyanidine oligosaccharide endocrine metabolic diseases powder of embodiment 4-, compares, including following component according to parts by weight: former
15 parts of 85 parts of 4.5 parts of plant extracts, inulin, the MCT powder of anthocyanidin >=95%, 1.3 parts of ground coffee, tea polyphenols >=95% tea
1.0 parts of extract, 1.2 parts of water soluble pearl powder, 1 part of the plant extracts of isoflavone content >=40%, digestant 200,000 are lived
Unit of force/0.6 part of gram edible protein enzyme.Wherein, the extraction raw material of procyanidine >=95% are as follows: grape pip, pine bark
And black fruit fructus lycii, the mass ratio of Semen Vitis viniferae extract, Pine Bark and black fruit fructus lycii extract are 2:3:1;The inulin
For the glycosylation inulin mixtures of the zeins containing mass ratio 0.1%;It is 1% that the MCT powder, which is containing mass ratio,
The MCT powder mixture of maltodextrin and 2% monoglyceride;The ground coffee is that either shallow bakes 6min at 180 DEG C, and is ground to grain
The coffee bean powder that diameter is 15~20 μm.
The preparation method of the MCT powder, includes the following steps:
(1) MCT, maltodextrin, monoglyceride are weighed in proportion, is added to the water dissolution, 10min is mixed, and it is mixed to obtain MCT
Close solution;
(2) MCT mixed solution is recycled 3 times under 80Mpa pressure using high pressure homogenizer, obtains MCT lotion;
(3) MCT emulsion spray is dry, sieving obtains finished product MCT powder.
A kind of preparation method of procyanidine oligosaccharide endocrine metabolic diseases powder of embodiment 5-, includes the following steps: that (1) will be former
Plant extracts, inulin, MCT powder, ground coffee, the tea extraction of tea polyphenols >=95%, water-soluble pearl of anthocyanidin >=95%
The plant extracts of powder, isoflavone content >=40%, digestant 200,000 unit of activity/gram edible protein enzyme, respectively through ultraviolet
After line sterilizing, 80~100 meshes are crossed through heated-air drying and obtain even-grained dry fine powder;
(2) by the component ratio in embodiment 4, the drying fine powder that step (1) obtains: the plant of procyanidine >=95% is weighed
Object extract, inulin, MCT powder, ground coffee, enter and mix 30-40min in three-dimensional mixer;Obtain preliminary mixed powder;
(3) by the component ratio in embodiment 4, weigh the drying fine powder that step (1) obtains: the tea of tea polyphenols >=95% is mentioned
Take object, water soluble pearl powder, the plant extracts of isoflavone content >=40%, digestant 200,000 unit of activity/gram table egg
White enzyme mixes 20~30min with the preliminary mixed powder in step (2) in three-dimensional mixer, and packing, sterilizing obtain packed
Procyanidine oligosaccharide endocrine metabolic diseases medicinal granules of powder
A kind of procyanidine oligosaccharide endocrine metabolic diseases powder of comparative example 1-, the difference with embodiment 4 are: procyanidine >=
95% extraction raw material are as follows: grape pip, ' Heijialun ' seed and ginkgo leaf, Semen Vitis viniferae extract, ' Heijialun ' seed and ginkgo leaf extract
The mass ratio of object is 2:3:1, remaining described parameter is same as Example 4.
A kind of procyanidine oligosaccharide endocrine metabolic diseases powder of comparative example 2-, the difference with embodiment 4 are: procyanidine >=
95% 2.5 parts of plant extracts, 100 parts of inulin, remaining parameter are same as Example 4.
A kind of procyanidine oligosaccharide endocrine metabolic diseases powder of comparative example 3-, the difference with embodiment 4 are: the inulin is
Glycosylation inulin mixtures containing the zeins that mass ratio is 0.5%, remaining parameter are same as Example 4.
A kind of procyanidine oligosaccharide endocrine metabolic diseases powder of comparative example 4-, the difference with embodiment 4 are: the MCT powder
For the MCT powder mixture for containing mass ratio being 1% maltodextrin and 2% stearoyl lactate, remaining parameter with 4 phase of embodiment
Together.
A kind of procyanidine oligosaccharide endocrine metabolic diseases powder of comparative example 5-, the difference with embodiment 4 are: the ground coffee
For at 210 DEG C either shallow bake 10min, and be ground to partial size be 15~20 μm, remaining parameter is same as Example 4.
A kind of preparation method of procyanidine oligosaccharide endocrine metabolic diseases powder of comparative example 6-, the difference with embodiment 5 are:
First by the plant extracts of procyanidine >=95%, the tea extraction of tea polyphenols >=95%, water soluble pearl powder, isoflavone content
>=40% plant extracts, digestant 200,000 unit of activity/gram edible protein enzyme enter after mixing in three-dimensional mixer, then
It is mixed with inulin, MCT powder, ground coffee, remaining step is same as Example 5.
1, pass through the procyanidine oligosaccharide endocrine metabolic diseases being prepared into detection Examples 1 to 5 and comparative example 1~6
Powder is as antioxidant, to the Scavenging activity (%) and inhibitory activity against tyrosinase (%) of DPPH free radical, more different originals
The antioxidant activity function of anthocyanidin oligosaccharide endocrine metabolic diseases powder, statistics and comparison result are as follows:
As can be seen from the above table, the procyanidine oligosaccharide endocrine metabolic diseases powder being prepared by the embodiment of the present invention 1~5,
It is apparently higher than comparative example 1~6 to the Scavenging activity and inhibitory activity against tyrosinase of DPPH free radical, and embodiment 3~5
Product is substantially better than Examples 1 to 2 to the inhibitory effect of tyrosinase.
Wherein, the plant extracts of procyanidine >=95% and inulin ratio are adjusted in comparative example 2, procyanidine is low
The inoxidizability of glycan endocrine metabolic diseases powder is substantially reduced, by embodiment 4 and the comparison of comparative example 3~5 as can be seen that using containing
The glycosylation inulin mixtures of the zeins of certain mass ratio, using the maltodextrin containing certain mass ratio and single sweet
The MCT powder mixture of rouge, and using the ground coffee baked by low temperature either shallow, Scavenging activity to the DPPH free radical of product and
Inhibitory activity against tyrosinase has large effect.Procyanidine oligosaccharide endocrine metabolic diseases powder is prepared by the present invention,
It can be conducive to the inoxidizability in body such as procyanidine, tea polyphenols, extend its effective component in people's intracorporal action time, mention
High definition removes interior free yl ability.
2, it is directed to product of the present invention, is special medicine purposes food.It is related to the health of human body, therefore we have done phase
The test of pass uses be prepared by Examples 1 to 5 and comparative example 1~6 respectively through every group of 35~65 years old 100 women personnel
Procyanidine oligosaccharide endocrine metabolic diseases powder this product after body be no different paradoxical reaction, can be seen using the skin behind after this product three days
To the effect that improves significantly.
(1) result judgement standard:
A. take 7 days: sleep improvement, energetic, the moon is improved, free movement of the bowels, vagina are wet, secretion elasticity increases
Add, enhancement of environment.
B. 15 days are taken: being had rosy cheeks, skin smooth, full of vitality, nympholepsy;Irregular menstruation, dysmenorrhea, leukorrhea, warp
Phase discomfort etc. mitigates;The recessiveness menopause symptom such as flush, hectic fever, perspiration, headache, palpitaition, vexed mitigates.
C. take 1~2 month: color spot shoals, breast is very swollen, elastic increase, nipple is stood upright, mammary areola color is pink, mammary gland increases
It is raw to mitigate;Eumenorrhea is obviously improved menstrual period discomfort, dysmenorrhea, leukorrhea, gynaecological imflammation etc.;Sexual desire enhancing, life quality mention
It is high;Maternity blues, fat improvement;Climacteric syndrome is eliminated;Cardiovascular and cerebrovascular disease, osteoporosis, pain in waist and lower extremities, cramp etc. are obvious
Improve.
D. take (> 2 months) for a long time: plump tall and straight, skin slip is in a cheerful frame of mind, is dynamic;Eumenorrhea, menstrual period are not
Suitable, dysmenorrhea, leukorrhea, gynaecological imflammation etc. are eliminated;Life quality improves;It postpones menopause, delay senescence;Climacteric disease is eliminated comprehensively
Shape;Effectively prevent cardiovascular and cerebrovascular disease, senile dementia, osteoporosis, the proliferation of mammary gland, breast cancer, uterine cancer, oophoroma and swells
Block.
Every group of personnel take under rear fruitful percentage such as table:
Embodiment | It takes 7 days | It takes 15 days | It takes 1~2 month | It takes for a long time |
Embodiment 1 | 90% | 92% | 94% | 96% |
Embodiment 2 | 88% | 90% | 93% | 95% |
Embodiment 3 | 91% | 93% | 96% | 97% |
Embodiment 4 | 92% | 94% | 96% | 98% |
Embodiment 5 | 92% | 96% | 98% | 99% |
Comparative example 1 | 63% | 65% | 68% | 70% |
Comparative example 2 | 40% | 43% | 45% | 48% |
Comparative example 3 | 35% | 38% | 40% | 43% |
Comparative example 4 | 42% | 44% | 47% | 49% |
Comparative example 5 | 38% | 41% | 44% | 46% |
Comparative example 6 | 58% | 60% | 63% | 65% |
As can be seen from the above table, by procyanidine oligosaccharide endocrine metabolic diseases powder obtained of the invention, have good
The synergistic effect for adjusting endocrine and digestion and absorption, promotes the decomposition of effective component to absorb, and increases absorption rate and curative effect is fast,
Conditioning effect outstanding feature.
The foregoing is merely illustrative of the preferred embodiments of the present invention, is not intended to limit the invention, all in essence of the invention
Within mind and principle, any modification, equivalent replacement, improvement and so on be should all be included in the protection scope of the present invention.
Claims (10)
1. a kind of procyanidine oligosaccharide endocrine metabolic diseases powder, it is characterised in that: compare according to parts by weight, including following component:
2. a kind of procyanidine oligosaccharide endocrine metabolic diseases powder according to claim 1, it is characterised in that: according to parts by weight
Number ratio, further includes the plant extracts of 0-1 parts of isoflavone content >=40%.
3. a kind of preparation method of procyanidine oligosaccharide endocrine metabolic diseases powder according to claim 2, it is characterised in that:
Compare according to parts by weight, further includes 0-1 parts of digestant 200,000 unit of activity/gram edible protein enzyme.
4. a kind of procyanidine oligosaccharide endocrine metabolic diseases powder according to claim 3, it is characterised in that: according to parts by weight
Number ratio, including following component:
5. a kind of procyanidine oligosaccharide endocrine metabolic diseases powder according to claim 1, it is characterised in that: the original cyanine
The extraction raw material of element >=95% are as follows: grape pip, pine bark and black fruit fructus lycii, Semen Vitis viniferae extract, Pine Bark and black
The mass ratio of fruit wolfberry fruit extract is (1~2): (1~3): (0.5~1).
6. a kind of procyanidine oligosaccharide endocrine metabolic diseases powder according to claim 1, it is characterised in that: the inulin is
The glycosylation inulin mixtures of zeins containing mass ratio 0.05~0.1%.
7. a kind of procyanidine oligosaccharide endocrine metabolic diseases powder according to claim 1, it is characterised in that: the MCT powder
For the MCT powder mixture for containing mass ratio being 0.3~1% maltodextrin and 0.1~2% monoglyceride.
8. a kind of procyanidine oligosaccharide endocrine metabolic diseases powder according to claim 7, it is characterised in that: the MCT powder
Preparation method, include the following steps:
(1) MCT, maltodextrin, monoglyceride are weighed in proportion, is added to the water dissolution, 5~10min is mixed, and it is mixed to obtain MCT
Close solution;
(2) MCT mixed solution is recycled 2~3 times under 80~100Mpa pressure using high pressure homogenizer, obtains MCT lotion;
(3) MCT emulsion spray is dry, sieving obtains finished product MCT powder.
9. a kind of procyanidine oligosaccharide endocrine metabolic diseases powder according to claim 1, it is characterised in that: the ground coffee
For at 160~180 DEG C either shallow bake 6~10min, and being ground to partial size is 15~20 μm of coffee bean powder.
10. a kind of preparation side of the procyanidine oligosaccharide endocrine metabolic diseases powder as described in any one of claim 1~9
Method, characterized by the following steps:
(1) by the plant extracts of procyanidine >=95%, inulin, MCT powder, ground coffee, tea polyphenols >=95% tea extraction,
The plant extracts of water soluble pearl powder, isoflavone content >=40%, digestant 200,000 unit of activity/gram edible protein enzyme,
Respectively after ultraviolet disinfection, 80~100 meshes are crossed through heated-air drying and obtain even-grained dry fine powder;
(2) weigh the drying fine powder that step (1) obtains in proportion: the plant extracts of procyanidine >=95%, inulin, MCT powder,
Ground coffee enters and mixes 30-40min in three-dimensional mixer;Obtain preliminary mixed powder;
(3) the drying fine powder that step (1) obtains is weighed in proportion: the tea extraction of tea polyphenols >=95%, water soluble pearl powder, different
It is first in the plant extracts of flavones content >=40%, digestant 200,000 unit of activity/gram edible protein enzyme, with step (2)
Step mixed powder mixes 20~30min in three-dimensional mixer, and packing, sterilizing obtain dividing in packed procyanidine oligosaccharide
Secrete adjusting medicinal granules of powder.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910908057.4A CN110495607A (en) | 2019-09-25 | 2019-09-25 | A kind of procyanidine oligosaccharide endocrine metabolic diseases powder and preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910908057.4A CN110495607A (en) | 2019-09-25 | 2019-09-25 | A kind of procyanidine oligosaccharide endocrine metabolic diseases powder and preparation method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110495607A true CN110495607A (en) | 2019-11-26 |
Family
ID=68592692
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910908057.4A Pending CN110495607A (en) | 2019-09-25 | 2019-09-25 | A kind of procyanidine oligosaccharide endocrine metabolic diseases powder and preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110495607A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111296728A (en) * | 2020-04-10 | 2020-06-19 | 武汉轻工大学 | Inulin compound induced by pulsed electric field and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1709383A (en) * | 2005-06-22 | 2005-12-21 | 白新鹏 | Beauty spot-eliminating capsule agent |
CN103815048A (en) * | 2014-02-12 | 2014-05-28 | 合肥康龄养生科技有限公司 | Inulin healthcare soybean milk and preparation method thereof |
-
2019
- 2019-09-25 CN CN201910908057.4A patent/CN110495607A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1709383A (en) * | 2005-06-22 | 2005-12-21 | 白新鹏 | Beauty spot-eliminating capsule agent |
CN103815048A (en) * | 2014-02-12 | 2014-05-28 | 合肥康龄养生科技有限公司 | Inulin healthcare soybean milk and preparation method thereof |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111296728A (en) * | 2020-04-10 | 2020-06-19 | 武汉轻工大学 | Inulin compound induced by pulsed electric field and preparation method thereof |
CN111296728B (en) * | 2020-04-10 | 2023-03-07 | 武汉轻工大学 | Inulin compound induced by pulsed electric field and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101518336A (en) | Nutrition food with oxidation resistance function and preparation method thereof | |
CN101253903B (en) | Health food with fat-reducing function and its preparation | |
KR101855821B1 (en) | Composition for relieving of menopausal symptoms and improving blood circulation | |
CN105942498A (en) | Functional nutritional food compounds with diabetes-treating effects and preparation methods thereof | |
CN107373672A (en) | A kind of irregular menstruation women tailored version clinical nutrition formula and preparation method thereof | |
CN102172269A (en) | Hidegelatin fabricated food with beautification function | |
CN106551398A (en) | A kind of anti-aging cream taste and preparation method thereof | |
CN108887564A (en) | A kind of selenoprotein coarse cereal powder formula and preparation method thereof | |
CN103082170A (en) | Synthesis rice for diabetes patients | |
CN109090617A (en) | It is a kind of to have effects that the formulation product of qi-supplementing, blood-engendering | |
CN106562428A (en) | Facial beautification and body shaping soft extract and preparation method thereof | |
CN106860680A (en) | Golden flower ginseng pressed candies and preparation method thereof | |
CN109247571A (en) | A kind of anti-aging health preserving health-care food and preparation method thereof | |
CN105918387A (en) | Healthcare food suitable for middle aged and elderly people and preparation method thereof | |
CN106923130A (en) | Solid beverage, its preparation method and application containing west safflower | |
CN104921133A (en) | Female cereal, vegetable and fruit nutritious food and preparation method thereof | |
CN106923115A (en) | Plant beverage containing west safflower and its preparation method and application | |
CN110495607A (en) | A kind of procyanidine oligosaccharide endocrine metabolic diseases powder and preparation method | |
CN111771970A (en) | Composition beneficial to nourishing and protecting stomach and preparation method thereof | |
CN107136281A (en) | It is a kind of to be used to improve kelp cordyceps sinensis pressed candy of women renal function and preparation method thereof | |
CN110237117A (en) | A kind of soft capsule and preparation method thereof of Menopause anti-aging | |
CN110638038A (en) | Medical formula nutritional meal replacement powder for controlling hyperglycemia and preparation method thereof | |
CN109965272A (en) | A kind of children's lead discharging tailored version clinical nutrition formula and preparation method thereof | |
CN109730222A (en) | Ferment complex liquid and its health drink | |
CN108095075A (en) | Miscarriage women tailored version clinical nutrition formula and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191126 |